BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8056421)

  • 1. Intraductal (intracystic) papillary carcinoma of the breast and its variants: a clinicopathological study of 77 cases.
    Lefkowitz M; Lefkowitz W; Wargotz ES
    Hum Pathol; 1994 Aug; 25(8):802-9. PubMed ID: 8056421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the clinicopathological characteristics and prognosis in 674 cases of breast intraductal papillary tumor].
    Wang WY; Wang X; Gao JD; Wang J; Liu JQ; Wang X; Zhao DB
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):429-433. PubMed ID: 28635232
    [No Abstract]   [Full Text] [Related]  

  • 3. Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis.
    Rakha EA; Gandhi N; Climent F; van Deurzen CH; Haider SA; Dunk L; Lee AH; Macmillan D; Ellis IO
    Am J Surg Pathol; 2011 Aug; 35(8):1093-103. PubMed ID: 21753694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.
    Collins LC; Carlo VP; Hwang H; Barry TS; Gown AM; Schnitt SJ
    Am J Surg Pathol; 2006 Aug; 30(8):1002-7. PubMed ID: 16861972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracystic papillary carcinoma: clinical presentation, patterns of practice, and oncological outcomes.
    Hassan Z; Boulos F; Abbas J; El Charif MH; Assi H; Sbaity E
    Breast Cancer Res Treat; 2020 Jul; 182(2):317-323. PubMed ID: 32462260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and outcome of patients with intracystic papillary carcinoma of the breast.
    Solorzano CC; Middleton LP; Hunt KK; Mirza N; Meric F; Kuerer HM; Ross MI; Ames FC; Feig BW; Pollock RE; Singletary SE; Babiera G
    Am J Surg; 2002 Oct; 184(4):364-8. PubMed ID: 12383904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraductal carcinoma of the breast: results of treatment with excisional biopsy and irradiation.
    Recht A; Danoff BS; Solin LJ; Schnitt S; Connolly J; Botnick L; Goldberg I; Goodman RL; Harris JR
    J Clin Oncol; 1985 Oct; 3(10):1339-43. PubMed ID: 2995597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracystic (encysted) papillary carcinoma of the breast: a clinical, pathological, and immunohistochemical study.
    Leal C; Costa I; Fonseca D; Lopes P; Bento MJ; Lopes C
    Hum Pathol; 1998 Oct; 29(10):1097-104. PubMed ID: 9781648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment.
    Solin LJ; Yeh IT; Kurtz J; Fourquet A; Recht A; Kuske R; McCormick B; Cross MA; Schultz DJ; Amalric R
    Cancer; 1993 Apr; 71(8):2532-42. PubMed ID: 8384070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of intracystic apocrine papillary tumor: diagnostic pitfalls for malignancy.
    Hayashi H; Ohtani H; Yamaguchi J; Shimokawa I
    Pathol Res Pract; 2013 Dec; 209(12):808-11. PubMed ID: 24095109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracystic papillary carcinoma of the breast: An in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up.
    Wynveen CA; Nehhozina T; Akram M; Hassan M; Norton L; Van Zee KJ; Brogi E
    Am J Surg Pathol; 2011 Jan; 35(1):1-14. PubMed ID: 21084964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoepithelial cells in solid variant of intraductal papillary carcinoma of the breast: a potential diagnostic pitfall and a proposal of an immunohistochemical panel in the differential diagnosis with intraductal papilloma with usual ductal hyperplasia.
    Moritani S; Ichihara S; Kushima R; Okabe H; Bamba M; Kobayashi TK; Hattori T
    Virchows Arch; 2007 May; 450(5):539-47. PubMed ID: 17377808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.
    Rosen PP; Groshen S; Saigo PE; Kinne DW; Hellman S
    J Clin Oncol; 1989 Sep; 7(9):1239-51. PubMed ID: 2549203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen-rich clear cell carcinoma of the breast. A clinicopathologic study of 21 cases.
    Hayes MM; Seidman JD; Ashton MA
    Am J Surg Pathol; 1995 Aug; 19(8):904-11. PubMed ID: 7611537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association with pregnancy increases the risk of local recurrence but does not impact overall survival in breast cancer: A case-control study of 87 cases.
    Genin AS; De Rycke Y; Stevens D; Donnadieu A; Langer A; Rouzier R; Lerebours F
    Breast; 2016 Dec; 30():222-227. PubMed ID: 26456897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast.
    Solin LJ; Fourquet A; McCormick B; Haffty B; Recht A; Schultz DJ; Barrett W; Fowble BL; Kuske R; Taylor M
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):3-9. PubMed ID: 8083125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High nuclear grade, frequent mitotic activity, cyclin D1 and p53 overexpression are associated with stromal invasion in mammary intracystic papillary carcinoma.
    Zhang C; Zhang P; Hao J; Quddus MR; Steinhoff MM; Sung CJ
    Breast J; 2005; 11(1):2-8. PubMed ID: 15647071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast.
    Ringberg A; Idvall I; Fernö M; Anderson H; Anagnostaki L; Boiesen P; Bondesson L; Holm E; Johansson S; Lindholm K; Ljungberg O; Ostberg G
    Eur J Surg Oncol; 2000 Aug; 26(5):444-51. PubMed ID: 11016463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrence after treatment of breast intraductal carcinoma].
    Jourdain O; Tunon de Lara C; Quenel N; Stöckle E; Bussières E; Faucher A; Acharian V; Vilbas-Guegan C; de Mascarel I; Trojani M; Dilhuydy JM; Avril A
    J Gynecol Obstet Biol Reprod (Paris); 1998 Jun; 27(4):403-12. PubMed ID: 9690159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.